SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-041709
Filing Date
2023-05-22
Accepted
2023-05-22 06:32:56
Documents
18
Period of Report
2023-05-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea178994-8k_enzobio.htm   iXBRL 8-K 42754
2 FORM OF DEBENTURE ea178994ex4-1_enzobio.htm EX-4.1 145839
3 FORM OF WARRANT ea178994ex4-2_enzobio.htm EX-4.2 96693
4 SECURITIES PURCHASE AGREEMENT, DATED MAY 19, 2023, BY AND AMONG ENZO BIOCHEM, IN ea178994ex10-1_enzobio.htm EX-10.1 248718
5 REGISTRATION RIGHTS AGREEMENT, DATED MAY 19, 2023, BY AND AMONG ENZO BIOCHEM, IN ea178994ex10-2_enzobio.htm EX-10.2 140513
6 SECURITY AGREEMENT, DATED MAY 19, 2023, BY AND AMONG ENZO BIOCHEM, INC., EACH OF ea178994ex10-3_enzobio.htm EX-10.3 155760
7 FORM OF SUBSIDIARY GUARANTEE ea178994ex10-4_enzobio.htm EX-10.4 73369
  Complete submission text file 0001213900-23-041709.txt   1290720

Data Files

Seq Description Document Type Size
8 XBRL LABEL FILE enz-20230519_lab.xml EX-101.LAB 34240
9 XBRL PRESENTATION FILE enz-20230519_pre.xml EX-101.PRE 22350
10 XBRL SCHEMA FILE enz-20230519.xsd EX-101.SCH 2944
12 EXTRACTED XBRL INSTANCE DOCUMENT ea178994-8k_enzobio_htm.xml XML 3477
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 23942364
SIC: 8071 Services-Medical Laboratories